Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HiCM-188 in End-Stage Heart Failure
NCT06866600Phase 2Not yet recruiting
- Sponsor
- Help Therapeutics
- Start
- Mar 2025
- Primary completion
- Dec 2027
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of HiCM-188 in Ischemic Heart Failure (IHF), sponsored by Help Therapeutics. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
HiCM-188
03
Conditions
Ischemic Heart Failure (IHF)
Beyond the preview
Go deeper on NCT06866600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06866600.